Milestone Pharmaceuticals (MIST) Market Capitalization (2019 - 2026)

Milestone Pharmaceuticals (MIST) has reported Market Capitalization for 8 consecutive years, with $166.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 60.75% year-over-year to $166.8 million; the trailing twelve-month figure through Jun 2026 stood at $166.8 million (up 60.75% YoY), and the FY2025 full-year result was $169.4 million, up 34.57% from the prior year.
• Market Capitalization rose to $166.8 million in Q2 2026 per MIST's latest filing, from $140.2 million in the prior quarter.
• Across five years, Market Capitalization topped out at $390.5 million in Q3 2022 and bottomed at $42.8 million in Q1 2025.
• Historically, Market Capitalization has averaged $151.1 million across 5 years, with a median of $134.5 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Market Capitalization tumbled 65.89% in 2023, then surged 227.69% in 2026.
• Over 5 years, Market Capitalization stood at $135.8 million in 2022, then tumbled by 47.16% to $71.7 million in 2023, then surged by 75.53% to $125.9 million in 2024, then soared by 34.57% to $169.4 million in 2025, then retreated by 1.54% to $166.8 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $166.8 million, $140.2 million, and $169.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.